Neuropace, Inc. · NASDAQ:NPCE

Orbimed Advisors LLC's stake in Neuropace, Inc. fell to 4.40% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Orbimed Advisors LLC's stake in Neuropace, Inc. fell to 4.40%, 1,505,125 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
4.40%
Shares
1,505,125
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC4.40%1,505,125
OrbiMed Capital GP VI LLC4.40%1,505,125

Source

View original at SEC

Related